Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18446052rdf:typepubmed:Citationlld:pubmed
pubmed-article:18446052lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C0011615lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C0037284lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C0333348lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C0056912lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:18446052lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:18446052pubmed:issue1lld:pubmed
pubmed-article:18446052pubmed:dateCreated2008-8-15lld:pubmed
pubmed-article:18446052pubmed:abstractTextAtopic dermatitis (AD) is a chronic inflammatory skin disease, for which no fundamental therapy exists. Immunostimulatory sequence CpG (ISS CpG) has potential in reducing susceptibility to allergic diseases and reversing established allergic reactions.lld:pubmed
pubmed-article:18446052pubmed:languageenglld:pubmed
pubmed-article:18446052pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:citationSubsetIMlld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18446052pubmed:statusMEDLINElld:pubmed
pubmed-article:18446052pubmed:issn1423-0097lld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:WangGuoyingGlld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:WolffHenrikHlld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:AleniusHarriHlld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:LauermaAntti...lld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:Dieu-NosjeanM...lld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:Fyhrquist-Van...lld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:KemenyLajosLlld:pubmed
pubmed-article:18446052pubmed:authorpubmed-author:HomeyBernardBlld:pubmed
pubmed-article:18446052pubmed:copyrightInfoCopyright 2008 S. Karger AG, Basel.lld:pubmed
pubmed-article:18446052pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18446052pubmed:volume147lld:pubmed
pubmed-article:18446052pubmed:ownerNLMlld:pubmed
pubmed-article:18446052pubmed:authorsCompleteYlld:pubmed
pubmed-article:18446052pubmed:pagination41-51lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:meshHeadingpubmed-meshheading:18446052...lld:pubmed
pubmed-article:18446052pubmed:year2008lld:pubmed
pubmed-article:18446052pubmed:articleTitleImmunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model.lld:pubmed
pubmed-article:18446052pubmed:affiliationUnit of Excellence for Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, Finland.lld:pubmed
pubmed-article:18446052pubmed:publicationTypeJournal Articlelld:pubmed